Description

This research service considers products and companies in the bone grafts and bone graft substitutes market in the United States. This market expects to witness many technology advancements in the next decade. A thorough analysis of revenue forecasts, unit forecasts, technological advances, and pricing are provided for the market’s various segments including: machine allografts, standard allografts, demineralized bone matrix, bone morphogenetic proteins (BMP), bone graft substitutes, and platelet concentration systems markets. Market engineering measurements, drivers, and restraints are covered along with an analysis of the market’s highly competitive landscape. The base year is 2011; the forecast period extends through 2016.